Concentrated stock management
Concentrated employer stock: six strategies, compared.
A director, executive, or senior employee with $1M-plus of employer stock faces two problems simultaneously. The first is a risk problem: a single name representing a large share of net worth is a portfolio risk that a diversified investor would not accept. The second is a compliance problem: blackout periods, MNPI access, Rule 144, and Section 16 constraints make selling difficult when you want to. Most executives default to "hold and wait" — which solves neither problem.
There are six strategies for managing concentrated employer stock. They differ in how much gain you defer, how soon you can sell, how much compliance clearance you need, and what you give up. This guide covers each one.
Why each strategy fits a different situation
Before comparing strategies, identify your constraints:
- Are you a Section 16 insider (officer or director)? If yes, Rule 144 and the no-short-swing-profit rule apply to every sale. Some strategies (collars, PVFs) can create Section 16 short-swing liability if structured incorrectly.
- Do you have MNPI access? If yes, a 10b5-1 plan is almost always the right compliance framework for a planned sell-down. Strategies that let you sell whenever you choose (like a DAF contribution or exchange fund) still need to happen outside a blackout window.
- What is your tax basis? If your cost basis is near zero (founder stock, very early-employee options), any sale-based strategy triggers a large taxable event. Deferral strategies — exchange funds, PVFs — are most valuable when basis is low.
- How much liquidity do you need now? If you need cash soon, a DAF or charitable strategy produces no liquidity for you. A PVF delivers cash upfront. A 10b5-1 plan delivers cash as sales execute — spread over months or years.
Strategy 1: 10b5-1 plan — gradual diversification with an affirmative defense
A 10b5-1 plan is a pre-scheduled trading instruction adopted when you have no MNPI. Once adopted and past the cooling-off period, trades execute automatically — you cannot intervene. The affirmative defense under Rule 10b5-1 protects those trades even if you later acquire MNPI. For any insider doing a planned, gradual diversification of employer stock, this is the core compliance framework.
For the detailed rules, see 10b5-1 plan rules, cooling-off periods, and the pre-adoption checklist. To model tax outcomes before adopting, use the concentration and tax calculator.
Strategy 2: Exchange fund — contribution for a diversified interest (IRC Section 721)
An exchange fund is a partnership that accepts contributions of concentrated stock from multiple investors in exchange for a pro-rata interest in the fund's pool of assets. The contribution is not a taxable event under IRC Section 721. After holding for at least seven years, investors can receive a diversified basket of shares — also not a taxable event. The gain deferred at contribution survives as embedded gain in the new shares (carryover basis).
Strategy 3: Prepaid variable forward (PVF) — upfront cash, deferred gain
In a prepaid variable forward, a financial institution pays you 80–95% of the current stock value upfront in exchange for your obligation to deliver shares (or the cash equivalent) at a future date, typically one to three years out. The transaction is structured so that you retain some downside exposure, which prevents it from being treated as a constructive sale under IRC Section 1259 — and so defers the taxable event until the delivery date.
Strategy 4: Zero-cost equity collar — downside protection without selling
A zero-cost collar pairs a protective put (you buy the right to sell at a floor price) with a covered call (you sell the right to buy at a ceiling price). The two premium values offset, so there is no net cost. The result: downside risk is capped at the put strike, and upside is capped at the call strike. You retain the shares and defer any taxable gain.
Strategy 5: Donor-advised fund (DAF) with appreciated stock
A DAF lets you donate appreciated stock directly to a sponsor organization, receive a fair-market-value charitable deduction, and avoid triggering capital gain on the donated shares. The DAF then sells the stock — as a tax-exempt entity, it pays no capital gains tax — and holds the proceeds for you to recommend grants to qualified charities over time.
Strategy 6: Charitable remainder trust (CRT) with appreciated stock
A CRT is an irrevocable trust that receives appreciated stock, sells it tax-free (the trust is tax-exempt), and then distributes an income stream to you (or other beneficiaries) for life or a term of years. At the end, the remaining assets pass to charity. You receive a partial charitable deduction at contribution equal to the present value of the projected charitable remainder.
Side-by-side comparison
| Strategy | Gain taxed when? | Upfront liquidity | Diversification | Insider complexity | Charitable benefit |
|---|---|---|---|---|---|
| 10b5-1 plan | As sales execute | None (proceeds arrive monthly/quarterly) | Full, over time | Designed for insiders | None |
| Exchange fund | Deferred 7+ years | None (illiquid 7 years) | Yes, at 7-year mark | Contribution must clear window | None |
| Prepaid variable forward | At delivery (1–3 yrs) | High (80–95% FMV now) | Partial (cash, not shares) | High — Section 16 analysis required | None |
| Zero-cost collar | When shares sold | None | None (you keep shares) | High — issuer policy may prohibit | None |
| Donor-advised fund | Never (trust sells tax-free) | None | Yes (charitable) | Moderate — window + pre-clearance | FMV deduction, 30% AGI limit |
| Charitable remainder trust | Never at trust level | None (income stream, not lump sum) | Yes (charitable) | Moderate — window + pre-clearance | Partial FMV deduction |
Why most insiders start with a 10b5-1 plan
The alternative strategies above are genuine tools, and a well-designed plan for a $3M-plus position often uses more than one. But for any executive or insider who needs a compliance-safe path to gradual diversification, the 10b5-1 plan is the starting point. It is the only strategy that was specifically designed to address MNPI constraints and trading-window limitations. The others are financial strategies that need to be carefully adapted to an insider's compliance constraints — sometimes by attorneys, not advisors.
A common multi-strategy scenario
A VP of Engineering holds $4M in employer stock (cost basis: $200K). Her advisor maps out a coordinated strategy: a 10b5-1 plan to sell $1.5M over 24 months and fund near-term financial goals, a DAF contribution of $250K in appreciated shares in year one to satisfy pledged charitable commitments with no capital gain, and retention of the remaining $2.25M position with a 10b5-1 plan renewing in year 3 for further diversification. The exchange fund was considered but declined — she wants liquidity, not a 7-year lock-in. No collar was needed because the 10b5-1 plan addressed the MNPI problem.
How an advisor coordinates these strategies
The financial mechanics of concentrated stock management — modeling sale cadences, projecting capital gain stacking, sizing DAF contributions against the AGI deduction ceiling, timing option exercises against planned sales — require someone with specific expertise in executive equity. The compliance layer — securities counsel review, broker coordination, pre-clearance, Form 144, Section 16 analysis — requires a separate legal team.
An advisor fluent in both areas serves as the central coordinator. They build the financial model that feeds into counsel's compliance review, so neither team is working in isolation. For a $3M position with RSUs, options, a 10b5-1 plan, and charitable giving, that coordination is where most of the financial value lives.
For broader context, see how executives manage stock sales, the year-end tax planning guide, and the concentration and LTCG calculator.
Managing a concentrated employer stock position?
We match executives, insiders, and concentrated-stock holders with fee-only advisors who specialize in 10b5-1 plans, equity-comp tax coordination, and concentrated stock strategies. Free match, no obligation.
Sources
- IRS Topic No. 409: Capital Gains and Losses — 2026 LTCG rates (0%, 15%, 20%) per IRS Rev. Proc. 2025-32; NIIT thresholds ($200K single / $250K MFJ, unindexed).
- Kitces: When To Use Exchange Funds To Diversify Concentrated Holdings — IRC 721 non-recognition rules, 7-year holding period under IRC 704(c)(1)(b), 20% illiquid asset requirement, and fee structures for exchange funds.
- SEC Release 33-11138: Amendments to Rule 10b5-1 — cooling-off periods, director/officer certifications, overlapping-plan limits, and good-faith requirement for 10b5-1 plans.
- IRS Publication 526: Charitable Contributions — 30% AGI limit for appreciated capital gain property contributed to donor-advised funds, five-year carryforward, and basis election rules for charitable contributions.
Tax rates and thresholds verified as of June 2026. IRC 1259 constructive sale analysis and Section 16 implications require legal counsel. This page is for informational purposes and does not constitute legal, tax, or investment advice.